Developing a molecular imaging agent for Met using onartuzumab (MetMAb).
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2602336226
